Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone deacetylase binding	MTA2 MTA1 MTA3	1.24e-03	147	29	3	GO:0042826
GeneOntologyBiologicalProcess	regulation of cell fate specification	MTA2 MTA1 MTA3	8.91e-06	29	29	3	GO:0042659
GeneOntologyBiologicalProcess	regulation of cell fate commitment	MTA2 MTA1 MTA3	5.58e-05	53	29	3	GO:0010453
GeneOntologyCellularComponent	NuRD complex	MTA2 MTA1 MTA3	1.45e-06	17	28	3	GO:0016581
GeneOntologyCellularComponent	CHD-type complex	MTA2 MTA1 MTA3	1.45e-06	17	28	3	GO:0090545
GeneOntologyCellularComponent	histone deacetylase complex	MTA2 MTA1 MTA3	1.97e-04	85	28	3	GO:0000118
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	MTA2 MTA1 MTA3	2.83e-04	96	28	3	GO:0070603
GeneOntologyCellularComponent	ATPase complex	MTA2 MTA1 MTA3	6.72e-04	129	28	3	GO:1904949
Domain	BAH	MTA2 MTA1 MTA3	6.12e-07	11	30	3	SM00439
Domain	BAH	MTA2 MTA1 MTA3	6.12e-07	11	30	3	PF01426
Domain	BAH_dom	MTA2 MTA1 MTA3	6.12e-07	11	30	3	IPR001025
Domain	BAH	MTA2 MTA1 MTA3	6.12e-07	11	30	3	PS51038
Domain	ZnF_GATA	MTA2 MTA1 MTA3	8.15e-07	12	30	3	SM00401
Domain	ELM2	MTA2 MTA1 MTA3	1.06e-06	13	30	3	SM01189
Domain	ELM2	MTA2 MTA1 MTA3	1.06e-06	13	30	3	PF01448
Domain	ELM2	MTA2 MTA1 MTA3	1.06e-06	13	30	3	PS51156
Domain	ELM2_dom	MTA2 MTA1 MTA3	1.06e-06	13	30	3	IPR000949
Domain	Znf_GATA	MTA2 MTA1 MTA3	1.68e-06	15	30	3	IPR000679
Domain	GATA	MTA2 MTA1 MTA3	1.68e-06	15	30	3	PF00320
Domain	GATA_ZN_FINGER_1	MTA2 MTA1 MTA3	2.06e-06	16	30	3	PS00344
Domain	GATA_ZN_FINGER_2	MTA2 MTA1 MTA3	2.06e-06	16	30	3	PS50114
Domain	SANT_dom	MTA2 MTA1 MTA3	9.48e-06	26	30	3	IPR017884
Domain	SANT	MTA2 MTA1 MTA3	1.19e-05	28	30	3	PS51293
Domain	Myb_DNA-binding	MTA2 MTA1 MTA3	2.36e-05	35	30	3	PF00249
Domain	MYB_LIKE	MTA2 MTA1 MTA3	3.04e-05	38	30	3	PS50090
Domain	-	TDRD15 TDRD6	3.73e-05	6	30	2	2.40.50.90
Domain	Staphylococal_nuclease_OB-fold	TDRD15 TDRD6	3.73e-05	6	30	2	IPR016071
Domain	SANT	MTA2 MTA1 MTA3	6.97e-05	50	30	3	SM00717
Domain	SANT/Myb	MTA2 MTA1 MTA3	7.84e-05	52	30	3	IPR001005
Domain	TUDOR	TDRD15 TDRD6	2.24e-04	14	30	2	PF00567
Domain	TUDOR	TDRD15 TDRD6	6.18e-04	23	30	2	PS50304
Domain	TUDOR	TDRD15 TDRD6	8.54e-04	27	30	2	SM00333
Domain	Tudor	TDRD15 TDRD6	1.06e-03	30	30	2	IPR002999
Domain	Homeodomain-like	MTA2 MTA1 MTA3 TSHZ2	1.87e-03	332	30	4	IPR009057
Pathway	REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	MTA2 MTA1 MTA3	5.95e-06	27	19	3	MM15537
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION	MTA2 MTA1 MTA3	9.11e-06	31	19	3	M48258
Pathway	WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA	MTA2 MTA1 MTA3	1.57e-05	37	19	3	M39756
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	MTA2 MTA1 MTA3	3.24e-05	47	19	3	MM15428
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	MTA2 MTA1 MTA3	3.24e-05	47	19	3	M1095
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	MTA2 MTA1 MTA3	5.21e-05	55	19	3	MM14932
Pathway	REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	MTA2 MTA1 MTA3	7.11e-05	61	19	3	M27811
Pathway	REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION	MTA2 MTA1 MTA3	1.32e-04	75	19	3	M27343
Pathway	REACTOME_HDACS_DEACETYLATE_HISTONES	MTA2 MTA1 MTA3	2.57e-04	94	19	3	M27230
Pathway	BIOCARTA_MTA3_PATHWAY	MTA1 MTA3	2.60e-04	18	19	2	M225
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	MTA2 MTA1 MTA3	2.83e-04	97	19	3	M48262
Pathway	REACTOME_PTEN_REGULATION	MTA2 MTA1 MTA3	2.91e-04	98	19	3	MM15348
Pathway	BIOCARTA_MTA3_PATHWAY	MTA1 MTA3	3.22e-04	20	19	2	MM1383
Pathway	REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	MTA2 MTA1 MTA3	3.57e-04	105	19	3	M27425
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS	MTA2 MTA1 MTA3	3.77e-04	107	19	3	M48260
Pathway	REACTOME_ADIPOGENESIS	MTA2 MTA1 MTA3	4.09e-04	110	19	3	M48259
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	MTA2 MTA1 MTA3	4.09e-04	110	19	3	M27696
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	MTA2 TRIM33 RIF1 MTA1	6.13e-04	301	19	4	MM15983
Pathway	REACTOME_PTEN_REGULATION	MTA2 MTA1 MTA3	8.10e-04	139	19	3	M27646
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	MTA2 MTA1 MTA3	8.61e-04	142	19	3	M48257
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	MTA2 MTA1 MTA3	1.09e-03	154	19	3	M39007
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	MTA2 MTA1 MTA3	1.57e-03	175	19	3	MM14941
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	MTA2 POLR3B MTA1 MTA3 ESRRG MAMLD1	1.71e-03	1022	19	6	MM15436
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	MTA2 MTA1 MTA3	4.43e-03	252	19	3	MM15585
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	MTA2 MTA1 MTA3	4.52e-03	254	19	3	M27131
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	MTA2 MTA1 MTA3	5.48e-03	272	19	3	M29619
Pubmed	Structure, expression and functions of MTA genes.	MTA2 MTA1 MTA3	6.41e-10	3	31	3	26869315
Pubmed	Identification and characterization of metastasis-associated gene/protein 1 (MTA1).	MTA2 MTA1 MTA3	6.41e-10	3	31	3	25315816
Pubmed	The Nucleosome Remodelling and Deacetylation complex suppresses transcriptional noise during lineage commitment.	MTA2 MTA1 MTA3	6.40e-09	5	31	3	31036553
Pubmed	The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex.	MTA2 MTA1 MTA3	3.58e-08	8	31	3	18067919
Pubmed	Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis.	MTA2 MTA1 MTA3	5.37e-08	9	31	3	26028330
Pubmed	RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene.	MTA2 MTA1 MTA3	5.37e-08	9	31	3	22926524
Pubmed	PWWP2B Fine-Tunes Adipose Thermogenesis by Stabilizing HDACs in a NuRD Subcomplex.	MTA2 MTA1 MTA3	7.66e-08	10	31	3	34180153
Pubmed	NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.	MTA2 MTA1 MTA3	1.40e-07	12	31	3	22560079
Pubmed	Metastasis tumor antigen 2 (MTA2) is involved in proper imprinted expression of H19 and Peg3 during mouse preimplantation development.	MTA2 MTA1 MTA3	1.40e-07	12	31	3	20720167
Pubmed	LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.	MTA2 MTA1 MTA3	1.82e-07	13	31	3	19703393
Pubmed	The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity.	MTA2 MTA1 MTA3	1.82e-07	13	31	3	12920132
Pubmed	MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.	MTA2 MTA1 MTA3	2.32e-07	14	31	3	16428440
Pubmed	NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.	MTA2 MTA1 MTA3	2.32e-07	14	31	3	25150861
Pubmed	NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development.	MTA2 MTA1 MTA3	2.90e-07	15	31	3	19927129
Pubmed	The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.	MTA2 MTA1 MTA3	2.90e-07	15	31	3	25247294
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MTA2 TRIM33 RIF1 MTA1 MTA3	3.69e-07	167	31	5	20362541
Pubmed	The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.	MTA2 MTA1 MTA3	5.18e-07	18	31	3	9790534
Pubmed	Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development.	MTA2 MTA1 MTA3	5.18e-07	18	31	3	23201013
Pubmed	Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.	MTA2 MTA1 MTA3	5.18e-07	18	31	3	10444591
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	MTA2 TRIM33 MTA1 MTA3	6.00e-07	75	31	4	25593309
Pubmed	FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.	MTA2 MTA1 MTA3	7.23e-07	20	31	3	27773593
Pubmed	Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.	MTA1 MTA3	7.69e-07	2	31	2	25319202
Pubmed	Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells.	MTA2 MTA3	7.69e-07	2	31	2	33744762
Pubmed	Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation.	MTA2 MTA1	7.69e-07	2	31	2	30642362
Pubmed	The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells.	MTA1 MTA3	7.69e-07	2	31	2	19363681
Pubmed	Assignment of the metastasis-associated gene (Mta1) to mouse chromosome band 12F and the metastasis-associated gene 2 (Mta2) to mouse chromosome band 19B by fluorescence in situ hybridization.	MTA2 MTA1	7.69e-07	2	31	2	11856890
Pubmed	Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells.	MTA2 RIF1 MTA1	1.28e-06	24	31	3	18454139
Pubmed	An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.	MTA2 TRIM33 MTA1 MTA3	1.31e-06	91	31	4	20362542
Pubmed	ATRX proximal protein associations boast roles beyond histone deposition.	MTA2 LTV1 MTA1 MTA3	1.31e-06	91	31	4	34780483
Pubmed	PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis.	MTA2 MTA1 MTA3	2.83e-06	31	31	3	29846670
Pubmed	Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.	MTA2 MTA1 MTA3	5.30e-06	38	31	3	33283408
Pubmed	The NuRD component Mbd3 is required for pluripotency of embryonic stem cells.	MTA2 MTA1	7.68e-06	5	31	2	16462733
Pubmed	Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.	MTA1 MTA3	7.68e-06	5	31	2	16502042
Pubmed	Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3.	MTA1 MTA3	7.68e-06	5	31	2	11483358
Pubmed	Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.	MTA2 MTA1 MTA3	8.87e-06	45	31	3	21258344
Pubmed	Murine Sall1 represses transcription by recruiting a histone deacetylase complex.	MTA2 MTA1	1.15e-05	6	31	2	11836251
Pubmed	The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early development.	MTA2 RIF1 MTA3	1.30e-05	51	31	3	22770845
Pubmed	CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.	MTA2 MTA1 MTA3	1.46e-05	53	31	3	34026424
Pubmed	Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4.	MTA2 MTA1	1.61e-05	7	31	2	10545197
Pubmed	Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates.	MTA2 MTA1	2.15e-05	8	31	2	18451879
Pubmed	Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.	MTA2 MTA3	2.15e-05	8	31	2	10471500
Pubmed	MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.	MTA2 MTA3	2.15e-05	8	31	2	12705869
Pubmed	Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex.	MTA2 MTA1	2.15e-05	8	31	2	18182442
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	MTA2 TRIM33 MTA1 MTA3 ESRRG	2.97e-05	411	31	5	35182466
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	MTA2 RIF1 MTA3 ESRRG	3.13e-05	203	31	4	22083510
Pubmed	Increased interaction between DJ-1 and the Mi-2/ nucleosome remodelling and deacetylase complex during cellular stress.	MTA2 MTA1	3.44e-05	10	31	2	20127688
Pubmed	BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.	MTA2 MTA1	3.44e-05	10	31	2	16091750
Pubmed	MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.	MTA2 MTA1	4.21e-05	11	31	2	15456747
Pubmed	Translational isoforms of FOG1 regulate GATA1-interacting complexes.	MTA2 MTA1	4.21e-05	11	31	2	19654328
Pubmed	The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.	MTA2 MTA1	5.05e-05	12	31	2	23708667
Pubmed	Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.	MTA2 MTA3	5.05e-05	12	31	2	21937684
Pubmed	NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.	MTA2 MTA1	5.05e-05	12	31	2	9885572
Pubmed	Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis.	MTA2 TRIM33 OR51B4	5.22e-05	81	31	3	24657165
Pubmed	Optimising experimental design for high-throughput phenotyping in mice: a case study.	MTA1 MTA3	5.96e-05	13	31	2	20799038
Pubmed	Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA.	MTA2 MTA1	6.95e-05	14	31	2	20585571
Pubmed	MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.	MTA2 MTA1	8.02e-05	15	31	2	15701600
Pubmed	Examining post-translational modification-mediated protein-protein interactions using a chemical proteomics approach.	MTA2 MTA1	1.04e-04	17	31	2	23281010
Pubmed	A Functional Switch of NuRD Chromatin Remodeling Complex Subunits Regulates Mouse Cortical Development.	MTA2 MTA1	1.04e-04	17	31	2	27806305
Pubmed	Transcription-coupled nucleotide excision repair is coordinated by ubiquitin and SUMO in response to ultraviolet irradiation.	MTA2 MTA1 MTA3	1.04e-04	102	31	3	31722399
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	MTA2 MTA1 MTA3	1.07e-04	103	31	3	32744500
Pubmed	A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.	MTA2 MTA1	1.17e-04	18	31	2	12493763
Pubmed	The functional interactome landscape of the human histone deacetylase family.	MTA2 RIF1 MTA1 MTA3	1.23e-04	289	31	4	23752268
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	MTA2 TRIM33 POLR3B MTA1 MTA3	1.28e-04	560	31	5	35241646
Pubmed	Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells.	MTA2 MTA1	1.92e-04	23	31	2	21670149
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	MTA2 LTV1 MTA1 MTA3	2.05e-04	330	31	4	33301849
Pubmed	Human transcription factor protein interaction networks.	TRIM33 RIF1 LTV1 MTA1 SMG7 MTA3 CCDC138	2.15e-04	1429	31	7	35140242
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MTA2 TRIM33 RIF1 POLR3B MTA1 MTA3	2.39e-04	1014	31	6	32416067
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	MTA2 MTA3	2.66e-04	27	31	2	23395962
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	UXS1 AADAT SMG7 MTA3 TSHZ2 SNX29 VPS13B	2.77e-04	1489	31	7	28611215
Pubmed	SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis.	MTA2 MTA1	2.86e-04	28	31	2	34163012
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	MTA2 MTA1 MTA3	2.99e-04	146	31	3	23892456
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	MTA2 MTA1 MTA3	3.23e-04	150	31	3	28242625
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	RIF1 MTA1 MTA3	3.43e-04	153	31	3	26365490
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	MTA2 MTA1 MTA3	3.70e-04	157	31	3	30186101
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	MTA2 TRIM33 MTA1 MTA3	4.08e-04	396	31	4	26687479
Pubmed	Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors.	MTA2 MTA1	4.49e-04	35	31	2	22325351
Pubmed	Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.	SMG7 CCDC138	5.30e-04	38	31	2	36674791
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MTA2 TRIM33 MTA1 MAMLD1	6.28e-04	444	31	4	34795231
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	MTA2 MTA1 MTA3	6.95e-04	195	31	3	19454010
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TRIM33 RIF1 SMG7 MAMLD1	6.99e-04	457	31	4	32344865
Pubmed	Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.	TRIM33 AKTIP LTV1 RAD54L ESRRG	7.85e-04	832	31	5	36724073
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	LTV1 SNX29 CCDC138	8.49e-04	209	31	3	36779422
Interaction	TFCP2L1 interactions	MTA2 TRIM33 RIF1 MTA1 MTA3	3.97e-07	99	31	5	int:TFCP2L1
Interaction	CHD5 interactions	MTA2 MTA1 SMG7 MTA3	5.73e-06	77	31	4	int:CHD5
Interaction	ZFPM2 interactions	MTA2 MTA1 MTA3	1.05e-05	28	31	3	int:ZFPM2
Interaction	ZNF827 interactions	MTA2 MTA1 MTA3	1.17e-05	29	31	3	int:ZNF827
Interaction	TCF19 interactions	MTA2 MTA1 MTA3	1.59e-05	32	31	3	int:TCF19
Interaction	SALL1 interactions	MTA2 MTA1 SMG7 MTA3	1.75e-05	102	31	4	int:SALL1
Interaction	MBD3L2 interactions	MTA2 MTA1 MTA3	3.38e-05	41	31	3	int:MBD3L2
Interaction	ESRRB interactions	MTA2 RIF1 MTA1 MTA3 ESRRG	4.61e-05	262	31	5	int:ESRRB
Interaction	NACC2 interactions	MTA2 MTA1 MTA3	5.44e-05	48	31	3	int:NACC2
Interaction	CDK2AP2 interactions	MTA2 MTA1 MTA3	5.79e-05	49	31	3	int:CDK2AP2
Interaction	FAM219A interactions	MTA2 MTA1 MTA3	6.15e-05	50	31	3	int:FAM219A
Interaction	LIN52 interactions	MTA2 MTA1 MTA3	6.53e-05	51	31	3	int:LIN52
Interaction	TRPS1 interactions	MTA2 MTA1 SMG7 MTA3	6.59e-05	143	31	4	int:TRPS1
Interaction	MTA1 interactions	MTA2 TRIM33 MTA1 MTA3 TSHZ2	6.64e-05	283	31	5	int:MTA1
Interaction	GSE1 interactions	MTA2 MTA1 SMG7 MTA3	8.79e-05	154	31	4	int:GSE1
Interaction	THRSP interactions	TRIM33 MTA1 MTA3	1.35e-04	65	31	3	int:THRSP
Interaction	MBD3L1 interactions	MTA2 MTA1 MTA3	1.68e-04	70	31	3	int:MBD3L1
Interaction	KPNA1 interactions	MTA2 TRIM33 POLR3B MTA1 MTA3	1.82e-04	351	31	5	int:KPNA1
Interaction	CCDC71 interactions	MTA2 MTA1 MTA3	1.83e-04	72	31	3	int:CCDC71
Interaction	H3C7 interactions	MTA2 MTA1 MTA3	1.91e-04	73	31	3	int:H3C7
Interaction	BCL11B interactions	MTA2 MTA1 MTA3	1.98e-04	74	31	3	int:BCL11B
Interaction	PHF20L1 interactions	MTA2 MTA1 MTA3	2.06e-04	75	31	3	int:PHF20L1
Interaction	PWWP2A interactions	MTA2 MTA1 MTA3	2.15e-04	76	31	3	int:PWWP2A
Interaction	BPTF interactions	MTA2 TRIM33 MTA1 MTA3	2.27e-04	197	31	4	int:BPTF
Interaction	POU5F1 interactions	MTA2 TRIM33 RIF1 MTA1 MTA3 ESRRG	2.29e-04	584	31	6	int:POU5F1
Interaction	ARID4B interactions	MTA2 LTV1 MTA1 MTA3	2.36e-04	199	31	4	int:ARID4B
Interaction	SALL4 interactions	MTA2 MTA1 MTA3	2.79e-04	83	31	3	int:SALL4
Interaction	CGB2 interactions	MTA2 MTA3	3.45e-04	18	31	2	int:CGB2
Interaction	ZNF219 interactions	MTA2 MTA1 MTA3	3.54e-04	90	31	3	int:ZNF219
Interaction	H3C1 interactions	MTA2 TRIM33 RIF1 LTV1 MTA1 MTA3 WDR87	3.57e-04	901	31	7	int:H3C1
Interaction	ERCC6 interactions	MTA2 RIF1 MTA1 MTA3	3.69e-04	224	31	4	int:ERCC6
Interaction	LIN37 interactions	MTA2 MTA1 MTA3	3.89e-04	93	31	3	int:LIN37
Interaction	L3MBTL2 interactions	MTA2 RIF1 MTA1 MTA3	4.15e-04	231	31	4	int:L3MBTL2
Interaction	STMN2 interactions	MTA2 MTA1 MTA3	4.41e-04	97	31	3	int:STMN2
Interaction	SHPRH interactions	MTA2 MTA1 MTA3	4.41e-04	97	31	3	int:SHPRH
Interaction	KDM5B interactions	MTA2 VGLL3 MTA3	4.82e-04	100	31	3	int:KDM5B
Interaction	BCL11A interactions	MTA2 MTA1 MTA3	5.10e-04	102	31	3	int:BCL11A
Interaction	ZFPM1 interactions	MTA2 MTA1	5.19e-04	22	31	2	int:ZFPM1
Interaction	BACC1 interactions	MTA2 MTA1 MTA3	5.40e-04	104	31	3	int:BACC1
Interaction	ASF1A interactions	MTA2 TRIM33 RIF1 MTA1	5.51e-04	249	31	4	int:ASF1A
Interaction	BUD13 interactions	MTA2 MTA1 MTA3	6.36e-04	110	31	3	int:BUD13
Interaction	HJURP interactions	MTA2 MTA1 MTA3	6.53e-04	111	31	3	int:HJURP
Interaction	LIN9 interactions	MTA2 MTA1 MTA3	6.53e-04	111	31	3	int:LIN9
Interaction	GSK3A interactions	LTV1 POLR3B SMG7 SNX29 CCDC138	6.56e-04	464	31	5	int:GSK3A
Interaction	CSNK2A2 interactions	MTA2 LTV1 POLR3B MTA1 SMG7 CCDC138	6.88e-04	718	31	6	int:CSNK2A2
Interaction	HMGXB4 interactions	MTA2 MTA1 MTA3	6.88e-04	113	31	3	int:HMGXB4
Interaction	NANOG interactions	MTA2 TRIM33 RIF1 MTA1 MTA3	7.72e-04	481	31	5	int:NANOG
Interaction	MTF2 interactions	MTA2 MTA1 MTA3	7.80e-04	118	31	3	int:MTF2
Interaction	CDK2AP1 interactions	MTA2 MTA1 MTA3	7.80e-04	118	31	3	int:CDK2AP1
Interaction	DPP6 interactions	UXS1 DPP10	7.85e-04	27	31	2	int:DPP6
Interaction	HMG20B interactions	MTA2 MTA1 MTA3	8.60e-04	122	31	3	int:HMG20B
Interaction	BRMS1L interactions	MTA2 MTA1 MTA3	9.22e-04	125	31	3	int:BRMS1L
Interaction	GATAD1 interactions	MTA2 MTA1 MTA3	1.06e-03	131	31	3	int:GATAD1
Interaction	ZBTB1 interactions	MTA2 TRIM33 OR51B4	1.13e-03	134	31	3	int:ZBTB1
Interaction	VPS18 interactions	AKTIP UXS1 MTA1	1.15e-03	135	31	3	int:VPS18
Interaction	IPO7 interactions	TRIM33 AKTIP UXS1 SMG7	1.16e-03	304	31	4	int:IPO7
Interaction	SUDS3 interactions	MTA2 MTA1 MTA3	1.31e-03	141	31	3	int:SUDS3
Interaction	CHAF1A interactions	MTA2 RIF1 MTA1 MTA3	1.43e-03	322	31	4	int:CHAF1A
Interaction	TCF20 interactions	MTA2 SMG7 MTA3	1.44e-03	146	31	3	int:TCF20
Interaction	SIN3B interactions	MTA2 MTA1 MTA3	1.47e-03	147	31	3	int:SIN3B
Interaction	TSHZ2 interactions	MTA1 TSHZ2	1.47e-03	37	31	2	int:TSHZ2
GeneFamily	PHD finger proteins\|NuRD complex	MTA2 MTA1 MTA3	3.42e-07	12	22	3	1305
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA2 MTA1 MTA3	7.05e-07	15	22	3	82
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA2 MTA1 MTA3	3.52e-05	53	22	3	532
GeneFamily	Tudor domain containing	TDRD15 TDRD6	9.17e-04	37	22	2	780
ToppCell	Club_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	TDRD6 DPP10 DNAH5	1.44e-04	147	31	3	5a824c89e4d045af465d7333275f8191fb29b041
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VGLL3 TSHZ2 ESRRG	1.78e-04	158	31	3	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	COVID-CD4-CD4_Treg\|COVID / Condition, Cell_class and T cell subcluster	POLR3B CCDC138 MAMLD1	1.81e-04	159	31	3	037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4\|Lung / Manually curated celltypes from each tissue	RP1 DNAH5 TSHZ2	1.91e-04	162	31	3	91cc14aec8d580cf97a1929bc1acb00fcbcdb57a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 DNAH5 ESRRG	1.98e-04	164	31	3	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-ILC3\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MMP25 TDRD15 POLR3B	1.98e-04	164	31	3	631ec9f54475dcc9d6b1c5bf6917e7fda4671034
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LTV1 TSHZ2 CCDC138	2.20e-04	170	31	3	b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 DPP10 ESRRG	2.28e-04	172	31	3	1565f38266891c3acf49778838de134c5dee5460
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AADAT DNAH5 AVIL	2.32e-04	173	31	3	f0eb48c1283bdde313bb75f6ffc0d2626922d24b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 TSHZ2 MAMLD1	2.48e-04	177	31	3	b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DNAH5 TSHZ2 MAMLD1	2.52e-04	178	31	3	0e1bedf991189d0ef9b40dac9281bdf4739333a1
ToppCell	ASK454-Epithelial-Ciliated\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	RP1 DNAH5 CCDC138	2.56e-04	179	31	3	f21919ef9d3d984e2925ef3d24f89e20fe265dcd
ToppCell	facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKTIP MTA1 PEX26	2.61e-04	180	31	3	7368ab31c3273374ef260f0d710d4eea83cbc4a2
ToppCell	facs-GAT-Fat-3m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RP1 DNAH5 ESRRG	2.65e-04	181	31	3	11cb84528f7ca084f0a92eda4f2e18e63a428fe9
ToppCell	facs-GAT-Fat-3m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RP1 DNAH5 ESRRG	2.65e-04	181	31	3	e97cbaafb93fdbee8e3cf4a06e6bcf121d941403
ToppCell	facs-GAT-Fat-3m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RP1 DNAH5 ESRRG	2.65e-04	181	31	3	5ffeca29e4d31a20c110d27af128ed024a79ad56
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	RP1 DNAH5 ESRRG	2.69e-04	182	31	3	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	RP1 DNAH5 ESRRG	2.82e-04	185	31	3	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	RP1 DPP10 DNAH5	2.82e-04	185	31	3	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 SNX29 ESRRG	2.87e-04	186	31	3	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	2.92e-04	187	31	3	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	COVID-19-kidney-Mito-rich_Distal\|kidney / Disease (COVID-19 only), tissue and cell type	RP1 DNAH5 ESRRG	2.92e-04	187	31	3	2ce8038d9d1302e850c1bb536e755598f77ba4b9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 SNX29 ESRRG	2.96e-04	188	31	3	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 DNAH5 ESRRG	3.01e-04	189	31	3	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RP1 DNAH5 ESRRG	3.01e-04	189	31	3	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.01e-04	189	31	3	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 DNAH5 ESRRG	3.01e-04	189	31	3	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	RP1 DNAH5 ESRRG	3.01e-04	189	31	3	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.01e-04	189	31	3	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 TSHZ2 MAMLD1	3.05e-04	190	31	3	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 TSHZ2 MAMLD1	3.05e-04	190	31	3	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RP1 DNAH5 ESRRG	3.10e-04	191	31	3	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VGLL3 TSHZ2 MAMLD1	3.10e-04	191	31	3	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RP1 DNAH5 ESRRG	3.10e-04	191	31	3	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RP1 DPP10 DNAH5	3.10e-04	191	31	3	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RP1 DNAH5 ESRRG	3.10e-04	191	31	3	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.15e-04	192	31	3	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.15e-04	192	31	3	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.15e-04	192	31	3	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SNX29 VPS13B ESRRG	3.15e-04	192	31	3	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.20e-04	193	31	3	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	TRIM33 VPS13B PUS7L	3.20e-04	193	31	3	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RP1 DNAH5 TSHZ2	3.20e-04	193	31	3	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 DNAH5 ESRRG	3.20e-04	193	31	3	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 DNAH5 ESRRG	3.20e-04	193	31	3	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.20e-04	193	31	3	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRIM33 TSHZ2 VPS13B	3.20e-04	193	31	3	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.25e-04	194	31	3	958e648138676d46698090b4046cb484083ae449
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.30e-04	195	31	3	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RP1 SNX29 ESRRG	3.30e-04	195	31	3	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.30e-04	195	31	3	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.30e-04	195	31	3	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	RP1 DNAH5 ESRRG	3.34e-04	196	31	3	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 TSHZ2 MAMLD1	3.34e-04	196	31	3	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 TSHZ2 MAMLD1	3.34e-04	196	31	3	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.34e-04	196	31	3	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.34e-04	196	31	3	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	RP1 DNAH5 ESRRG	3.34e-04	196	31	3	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 TSHZ2 MAMLD1	3.40e-04	197	31	3	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RP1 DNAH5 TSHZ2	3.45e-04	198	31	3	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DPP10 TSHZ2 ESRRG	3.45e-04	198	31	3	af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 TSHZ2 MAMLD1	3.45e-04	198	31	3	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	IPF-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	TDRD6 SNX29 MAMLD1	3.50e-04	199	31	3	3c2b362d5e824e1a04830e70352f8818de984174
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	RIF1 VGLL3 RAD54L	3.55e-04	200	31	3	691b3edf7d8449556e8bf611662eb85772959f0f
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	RIF1 VGLL3 RAD54L	3.55e-04	200	31	3	4e077aa7faddcebdfc54667f8b3990704441005b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	RIF1 VGLL3 RAD54L	3.55e-04	200	31	3	d17ba4239e1fd702a3d757687110f0f2c6f91ef7
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	RIF1 VGLL3 RAD54L	3.55e-04	200	31	3	36a110aa91a791fdf1142e7869e8aa0d342402d0
Drug	6-methylenetestosterone acetate	MTA2 MTA1 MTA3	4.56e-08	6	31	3	CID000159323
Drug	STOCK1N-28457; Up 200; 20uM; PC3; HT_HG-U133A	VGLL3 MTA1 SMG7 SNX29 PEX26	6.52e-06	197	31	5	6864_UP
Disease	neuroblastoma	MMP25 TDRD15 DNAH5	2.01e-04	116	29	3	EFO_0000621
Disease	autism	TRIM33 ESRRG	1.02e-03	48	29	2	EFO_0003758
Disease	facial morphology measurement	AKTIP UXS1 VGLL3 VPS13B	1.07e-03	466	29	4	EFO_0007841
Disease	adverse effect, response to xenobiotic stimulus	DPP10 ESRRG	1.54e-03	59	29	2	EFO_0009658, GO_0009410
Disease	low density lipoprotein cholesterol measurement, physical activity	TDRD15 RP1	1.92e-03	66	29	2	EFO_0003940, EFO_0004611
Disease	psychotic symptoms	TSHZ2 SNX29	2.41e-03	74	29	2	EFO_0005940
Disease	unipolar depression, alcohol dependence	RIF1 ESRRG	2.67e-03	78	29	2	EFO_0003761, MONDO_0007079
Disease	thyroxine measurement	AADAT SNX29	3.02e-03	83	29	2	EFO_0005130
Disease	sleep duration, low density lipoprotein cholesterol measurement	TDRD15 SNX29	3.62e-03	91	29	2	EFO_0004611, EFO_0005271
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	TDRD15 RP1	4.26e-03	99	29	2	EFO_0004611, EFO_0007878
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	TDRD15 RP1	4.52e-03	102	29	2	EFO_0004329, EFO_0004611
Disease	attention deficit hyperactivity disorder	DPP10 MTA3 TSHZ2	4.96e-03	354	29	3	EFO_0003888
Disease	amyloid-beta measurement	RP1 DPP10 TSHZ2	5.00e-03	355	29	3	EFO_0005194
Disease	lower face morphology measurement	VGLL3 VPS13B	5.14e-03	109	29	2	EFO_0010948
Disease	Precancerous Conditions	DPP10 MAGED4	5.24e-03	110	29	2	C0032927
Disease	Condition, Preneoplastic	DPP10 MAGED4	5.24e-03	110	29	2	C0282313
Disease	seasonal gut microbiome measurement	DPP10 ESRRG	5.42e-03	112	29	2	EFO_0007753
Disease	brain aneurysm	RP1 ESRRG	5.52e-03	113	29	2	EFO_0003870
Disease	factor VIII measurement, coronary artery disease	TDRD15 RP1	5.52e-03	113	29	2	EFO_0001645, EFO_0004630
Disease	age at first sexual intercourse measurement	VGLL3 TSHZ2 SNX29	6.17e-03	383	29	3	EFO_0009749
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	AKTIP SNX29 ESRRG	6.86e-03	398	29	3	EFO_0003756, EFO_0003888, EFO_0004337

Protein segments in the cluster

Peptide	Gene	Start	Entry
EYQANNQYIPKPKPA	UXS1	396	Q8NBZ7
PQKNTPKFLYTVPNG	AADAT	186	Q8N5Z0
PKYYPIAVLLKNQNQ	AVIL	756	O75366
VVKQKLPGVYVQPSY	AKTIP	86	Q9H8T0
PYPKAGQVNPTIKLY	DPP10	281	Q8N608
LKQVYIPTYTKPNPN	MTA2	331	O94776
SILSKPFKVPIPNYQ	RAD54L	76	Q92698
QQLYGKAPQTPYDKP	MMP25	276	Q9NPA2
YNHPQLIKYQPKPKQ	LTV1	361	Q96GA3
QKYLEYKKIPNSNPP	MAGED4	556	Q96JG8
PPFVNPIIYSIKTKQ	OR51B4	281	Q9Y5P0
VLQYYQVPEKLPPKV	PEX26	106	Q7Z412
PVSKTYKVPLNGQVY	CCDC138	341	Q96M89
YLNPQLVQPAKKPYN	ESRRG	221	P62508
LTIPPKTKYHYQPQL	C1orf100	56	Q5SVJ3
KGPTVPYYEKINSVP	MAMLD1	156	Q13495
NLPIPVQTKNYYKNV	DNAH5	1096	Q8TE73
QNINPYPTLKPIKSA	RP1	921	P56715
QVYIPTYSKPNPNQI	MTA3	336	Q9BTC8
VPASIPNYYKIIKKP	TRIM33	986	Q9UPN9
QNKYPQVRAYNFPPK	SNX29	706	Q8TEQ0
PLKQKQPGLDYFYPQ	TDRD6	231	O60522
LPQPQIYLNAKVKGY	TDRD15	1286	B5MCY1
LPVLGYNIQYPKNKV	PUS7L	596	Q9H0K6
PYNIKYQPKVKSPQR	RIF1	771	Q5UIP0
VKQPYYLQTQDPIKL	SMG7	816	Q92540
LKQVYIPNYNKPNPN	MTA1	351	Q13330
PQQPQYKDVPITYKG	POLR3B	846	Q9NW08
DPLQKPLDPTIKYQY	TSHZ2	486	Q9NRE2
PYQIFYKPQLSVCNP	VPS13B	3116	Q7Z7G8
AYYQPAPQPGQQKKL	VGLL3	31	A8MV65
VPKYIYPGQAQQKLV	WDR87	676	Q6ZQQ6